Lung volumes and lung capacities refer to the volume of air in the lungs at different phases of the respiratory cycle.
The average total lung capacity of an adult human male is about 6 litres of air.[1]
Tidal breathing is normal, resting breathing; the tidal volume is the volume of air that is inhaled or exhaled in only a single such breath.
The average human respiratory rate is 30–60 breaths per minute at birth,[2] decreasing to 12–20 breaths per minute in adults.[3
This document provides information on pulmonary function testing and spirometry. It defines key lung volumes and capacities that are measured, such as FVC, FEV1, FRC, RV. Normal values for various pulmonary function tests are provided. Spirometry is described as the most common pulmonary function test used to measure breath volume and flow. The document outlines the technique for spirometry and how to interpret the results to determine if a restrictive or obstructive ventilatory pattern is present. Limitations of spirometry and contraindications to its use are also discussed.
This document provides information on pulmonary function testing and spirometry. It defines key lung volumes and capacities that are measured, such as FVC, FEV1, FRC, RV. Normal values for various pulmonary function tests are provided. Spirometry is described as the most common pulmonary function test used to measure breath volume and flow. The document outlines the technique for spirometry and how to interpret the results to determine if a restrictive or obstructive ventilatory pattern is present. Limitations of spirometry and contraindications to its use are also discussed.
The document discusses lung volumes, capacities, and pulmonary function tests. Key points include:
- Pulmonary function testing measures ventilation, diffusion, and blood flow to evaluate lung health. Spirometry is the cornerstone test and measures volumes inhaled and exhaled over time.
- Other tests include lung volume determination, diffusing capacity tests, and six-minute walk tests. Results are compared to predicted normal values.
- Spirometry evaluates the airways and lung parenchyma. It measures volumes like forced vital capacity and flows like FEV1. Pattern recognition from these values helps diagnose restrictive or obstructive lung diseases.
- Flow-volume loops provide additional information, showing concave loops in asthma and dog-
Pulmonary function tests provide objective measurements of lung function to assess respiratory dysfunction. They can predict and characterize pulmonary disease as obstructive or restrictive. Key tests measure vital capacity, forced expiratory volume in one second, and other lung volumes and capacities. Abnormal values help determine disease severity and perioperative risk. Spirometry is the cornerstone test, using flow-volume curves and spirograms to distinguish obstructive from restrictive patterns. Bedside tests also evaluate cough strength, wheezing, and breathing capacity.
Pulmonary function tests (PFTs) are a group of standardized maneuvers and measurements used to diagnose and monitor pulmonary diseases and assess treatment effectiveness. PFTs measure lung volumes, capacity, flows, and gas exchange. Key tests include spirometry, which measures volumes and flows, and diffusion capacity testing, which assesses the alveolar-capillary membrane. PFTs can distinguish between obstructive diseases like asthma, which reduce expiratory flows, and restrictive diseases like fibrosis, which decrease lung volumes and capacity. The results of PFTs are used to diagnose pulmonary abnormalities, determine disease severity, and monitor response to treatment.
Pulmonary function tests (PFTs) are a group of standardized maneuvers and measurements used to diagnose and monitor pulmonary diseases and assess treatment effectiveness. PFTs measure lung volumes, capacity, flows, and gas exchange. Key tests include spirometry, which measures volumes and flows, and diffusion capacity testing, which assesses the alveolar-capillary membrane. PFTs can distinguish between obstructive diseases like asthma, which reduce expiratory flows, and restrictive diseases like fibrosis, which decrease lung volumes and capacity. The results of PFTs are used to diagnose pulmonary abnormalities, determine disease severity, and monitor response to treatment.
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATIONLincyAsha
PULMONARY FUNCTION TESTS
LAB DATA INTERPRETATION
CLINICAL PHARMACY PRACTICE
M.PHARMACY
PHARMACY PRACTICE
1ST YEAR
Pulmonary function tests are a series of tests performed to examine a patient’s respiratory system and identify the severity of pulmonary impairment.
These tests are performed to measure a patient’s lung volume, capacity, flow rate and gas exchange.
This allows medical professionals to obtain an accurate diagnosis and determine the best course of medical intervention for the patient.
In general there are two types of lung disorders that these tests can be used to assess
Obstructive lung diseases
Restrictive lung diseases
1.OBSTRUCTIVE LUNG DISEASES
It include conditions that make it difficult to exhale air out of the lungs
This results in shortness of breath that occurs from narrowing and constriction of the airways and causes the patient to have decreased flow rates. Eg. COPD, Asthma
2.RESTRICTIVE LUNG DISEASES
It include conditions that make it difficult to fully fill the lungs with air during inhalation.
When the lungs aren’t fully able to expand it causes the patient to have decreased lung volumes. Eg. Pulmonary fibrosis, interstitial lung disease
Pulmonary function tests would be indicated for the following:
On healthy patients as part of a routine physical exam
Evaluate signs and symptoms of lung disease
Diagnosis of certain medical conditions
Measure current stage of disease and evaluate its progress
Assess how a patient is responding to different treatments
Determine patient’s condition before surgery to assess the risk of respiratory complications
Screen people who are at risk of pulmonary disease
Determine how much a patient’s airways have narrowed due to disorders
In certain types of work environments to assess the health of employees.
Additionally PFTs may be indicated for the following
Chronic lung conditions
Restrictive airway problems
Asthma
COPD
Shortness of breath
Impairment or disability
Early morning wheezing
Chest muscle weakness
Lung cancer
Respiratory infections
STATIC LUNG VOLUMES
Lung volume is the amount of air breathed by an individual under a specific condition.
1.Tidal Volume (TV)
It is the volume of air inspired or expired during normal breathing at rest.
2.Inspiratory Reserve Volume (IRV)
It is the volume of air inspired with maximum effort over and above the normal tidal volume.
3.Expiratory Reserve Volume (ERV)
It is the volume of air expired forcefully after a normal respiration.
4.Residual Volume (RV)
It is the volume of air remaining in the lungs after a forceful expiration
STATIC LUNG CAPACITIES
1.Inspiratory capacity (IC)
It is the amount of air a person can inspire forcefully after a normal respiration.
IC = TV+IRV
2.Functional Residual Capacity (FRC)
It is the amount of air that remains in the lungs at the end of normal respiration.
FRC = ERV+RV
3.Vital Capacity (VC)
It is the maximum volume of air exhaled forcefully from the lungs after a maximum inspiration.
4.Total Lung Capacity
This document provides information on pulmonary function testing and spirometry. It defines key lung volumes and capacities that are measured, such as FVC, FEV1, FRC, RV. Normal values for various pulmonary function tests are provided. Spirometry is described as the most common pulmonary function test used to measure breath volume and flow. The document outlines the technique for spirometry and how to interpret the results to determine if a restrictive or obstructive ventilatory pattern is present. Limitations of spirometry and contraindications to its use are also discussed.
This document provides information on pulmonary function testing and spirometry. It defines key lung volumes and capacities that are measured, such as FVC, FEV1, FRC, RV. Normal values for various pulmonary function tests are provided. Spirometry is described as the most common pulmonary function test used to measure breath volume and flow. The document outlines the technique for spirometry and how to interpret the results to determine if a restrictive or obstructive ventilatory pattern is present. Limitations of spirometry and contraindications to its use are also discussed.
The document discusses lung volumes, capacities, and pulmonary function tests. Key points include:
- Pulmonary function testing measures ventilation, diffusion, and blood flow to evaluate lung health. Spirometry is the cornerstone test and measures volumes inhaled and exhaled over time.
- Other tests include lung volume determination, diffusing capacity tests, and six-minute walk tests. Results are compared to predicted normal values.
- Spirometry evaluates the airways and lung parenchyma. It measures volumes like forced vital capacity and flows like FEV1. Pattern recognition from these values helps diagnose restrictive or obstructive lung diseases.
- Flow-volume loops provide additional information, showing concave loops in asthma and dog-
Pulmonary function tests provide objective measurements of lung function to assess respiratory dysfunction. They can predict and characterize pulmonary disease as obstructive or restrictive. Key tests measure vital capacity, forced expiratory volume in one second, and other lung volumes and capacities. Abnormal values help determine disease severity and perioperative risk. Spirometry is the cornerstone test, using flow-volume curves and spirograms to distinguish obstructive from restrictive patterns. Bedside tests also evaluate cough strength, wheezing, and breathing capacity.
Pulmonary function tests (PFTs) are a group of standardized maneuvers and measurements used to diagnose and monitor pulmonary diseases and assess treatment effectiveness. PFTs measure lung volumes, capacity, flows, and gas exchange. Key tests include spirometry, which measures volumes and flows, and diffusion capacity testing, which assesses the alveolar-capillary membrane. PFTs can distinguish between obstructive diseases like asthma, which reduce expiratory flows, and restrictive diseases like fibrosis, which decrease lung volumes and capacity. The results of PFTs are used to diagnose pulmonary abnormalities, determine disease severity, and monitor response to treatment.
Pulmonary function tests (PFTs) are a group of standardized maneuvers and measurements used to diagnose and monitor pulmonary diseases and assess treatment effectiveness. PFTs measure lung volumes, capacity, flows, and gas exchange. Key tests include spirometry, which measures volumes and flows, and diffusion capacity testing, which assesses the alveolar-capillary membrane. PFTs can distinguish between obstructive diseases like asthma, which reduce expiratory flows, and restrictive diseases like fibrosis, which decrease lung volumes and capacity. The results of PFTs are used to diagnose pulmonary abnormalities, determine disease severity, and monitor response to treatment.
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATIONLincyAsha
PULMONARY FUNCTION TESTS
LAB DATA INTERPRETATION
CLINICAL PHARMACY PRACTICE
M.PHARMACY
PHARMACY PRACTICE
1ST YEAR
Pulmonary function tests are a series of tests performed to examine a patient’s respiratory system and identify the severity of pulmonary impairment.
These tests are performed to measure a patient’s lung volume, capacity, flow rate and gas exchange.
This allows medical professionals to obtain an accurate diagnosis and determine the best course of medical intervention for the patient.
In general there are two types of lung disorders that these tests can be used to assess
Obstructive lung diseases
Restrictive lung diseases
1.OBSTRUCTIVE LUNG DISEASES
It include conditions that make it difficult to exhale air out of the lungs
This results in shortness of breath that occurs from narrowing and constriction of the airways and causes the patient to have decreased flow rates. Eg. COPD, Asthma
2.RESTRICTIVE LUNG DISEASES
It include conditions that make it difficult to fully fill the lungs with air during inhalation.
When the lungs aren’t fully able to expand it causes the patient to have decreased lung volumes. Eg. Pulmonary fibrosis, interstitial lung disease
Pulmonary function tests would be indicated for the following:
On healthy patients as part of a routine physical exam
Evaluate signs and symptoms of lung disease
Diagnosis of certain medical conditions
Measure current stage of disease and evaluate its progress
Assess how a patient is responding to different treatments
Determine patient’s condition before surgery to assess the risk of respiratory complications
Screen people who are at risk of pulmonary disease
Determine how much a patient’s airways have narrowed due to disorders
In certain types of work environments to assess the health of employees.
Additionally PFTs may be indicated for the following
Chronic lung conditions
Restrictive airway problems
Asthma
COPD
Shortness of breath
Impairment or disability
Early morning wheezing
Chest muscle weakness
Lung cancer
Respiratory infections
STATIC LUNG VOLUMES
Lung volume is the amount of air breathed by an individual under a specific condition.
1.Tidal Volume (TV)
It is the volume of air inspired or expired during normal breathing at rest.
2.Inspiratory Reserve Volume (IRV)
It is the volume of air inspired with maximum effort over and above the normal tidal volume.
3.Expiratory Reserve Volume (ERV)
It is the volume of air expired forcefully after a normal respiration.
4.Residual Volume (RV)
It is the volume of air remaining in the lungs after a forceful expiration
STATIC LUNG CAPACITIES
1.Inspiratory capacity (IC)
It is the amount of air a person can inspire forcefully after a normal respiration.
IC = TV+IRV
2.Functional Residual Capacity (FRC)
It is the amount of air that remains in the lungs at the end of normal respiration.
FRC = ERV+RV
3.Vital Capacity (VC)
It is the maximum volume of air exhaled forcefully from the lungs after a maximum inspiration.
4.Total Lung Capacity
Spirometry is a simple, inexpensive pulmonary function test used to evaluate respiratory diseases. It measures how much air a person can inhale and exhale. Sir John Hutchinson invented the first spirometer to measure vital capacity. Spirometry can identify obstructive and restrictive lung diseases, establish reversibility in asthma, screen smokers for risk, and monitor treatment effectiveness. It involves maximal inhalation and exhalation into a mouthpiece to measure volumes like forced vital capacity and flows like forced expiratory volume in one second. Graphs of the results can indicate normal lung function or patterns suggestive of various respiratory conditions.
Pulmonary function testing is the process of having the patient perform specific inspiratory and expiratory maneuvers while breathing in and out of tubing attached to the equipment that measure a variety of variables
Pulmonary function tests (PFTs) evaluate lung function through non-invasive tests. PFTs can be done at bedside or in traditional labs and include tests of lung volumes, capacities, flows and gas exchange. Bedside PFTs include breath-holding tests to assess vital capacity, single-breath tests for functional residual capacity, cough tests for strength, blowing tests for maximum breathing capacity, and peak flow tests. PFTs help diagnose and monitor pulmonary diseases, assess disease severity and surgical risk, and track response to treatment. Common diseases detected include obstructive disorders like asthma which limit expiration and restrictive disorders like fibrosis which limit both expiration and inspiration.
This document discusses pulmonary function tests (PFTs), including their goals, uses, limitations, procedures, and interpretations. PFTs are used to assess lung function before surgeries and characterize any pulmonary dysfunction. Key information obtained from PFTs includes measurements of forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), their ratio (FEV1/FVC), and peak expiratory flow rate. Interpretations of these values can indicate restrictive or obstructive lung disease. The document outlines how PFTs are performed using portable devices or clinic spirometers and flow-volume loops.
Spirometry is a common pulmonary function test that measures lung volume and airflow. It is performed using a spirometer to detect respiratory diseases like asthma and distinguish between obstructive and restrictive lung diseases. The test involves taking deep breaths and forcibly exhaling for 6 seconds to measure volumes like forced vital capacity and forced expiratory volume in 1 second. Spirometry is generally safe but may cause shortness of breath and is not performed following a heart attack or other heart conditions.
Spirometry is a test used to assess lung function by measuring airflow. It can help diagnose obstructive lung diseases like COPD and asthma by measuring airflow limitation through values like FEV1 and FEV1/FVC ratio. A spirometry report provides values for volumes of air inhaled and exhaled that are compared to predicted normal values to identify restrictive or obstructive lung abnormalities. Quality control measures ensure accurate spirometry administration and interpretation.
This document provides an overview of pulmonary function tests (PFTs). It discusses:
1. The classification and types of PFTs including mechanical ventilatory functions tests, lung volumes/capacities tests, spirometry, and gas exchange function tests.
2. How to interpret PFT results including evaluating the FEV1/FVC ratio to determine obstruction and evaluating the FVC to identify restriction.
3. Key aspects of spirometry like acceptability criteria, interpreting volume-time and flow-volume curves, and confirming restrictive patterns.
This document discusses lung volumes and capacities as measured by pulmonary function tests (PFTs). It describes the key volumes and capacities including tidal volume, inspiratory reserve volume, expiratory reserve volume, residual volume, vital capacity, total lung capacity, and functional residual capacity. It provides the normal ranges for these measurements and explains their clinical significance in assessing lung function and the presence of obstructive or restrictive lung diseases. Spirometry is highlighted as the cornerstone PFT for measuring volumes like forced vital capacity (FVC) and flows like forced expiratory volume in 1 second (FEV1).
Lung volumes and capacities can be divided into static and dynamic measurements. Static measurements do not consider time and include tidal volume, inspiratory reserve volume, expiratory reserve volume, and residual volume. Dynamic measurements involve time and include forced vital capacity, peak expiratory flow rate, and maximum voluntary ventilation. Forced vital capacity is measured in two stages after full inhalation and exhalation and provides information about respiratory muscle strength and pulmonary function. Factors like age, posture, and respiratory obstruction can impact lung volumes and capacities.
Dr. M.MADHU CHAITANYA presented on pulmonary function tests. PFTs are a battery of standardized tests used to evaluate aspects of the respiratory system, including lung mechanics, gas exchange, and cardiopulmonary interaction. Common PFTs include spirometry to measure volumes like FVC and rates like FEV1, lung volume measurements via body plethysmography or other methods, and gas exchange tests. PFTs are used to diagnose and monitor respiratory conditions, and to evaluate patients preoperatively by assessing cardiopulmonary reserve and risk of complications. The presentation covered techniques, normal values, and clinical applications of various PFTs.
Pulmonary function tests (PFTs) evaluate the different components of the respiratory system including the airways, lungs, blood vessels and chest wall muscles. Spirometry is the most common PFT and measures how much air the patient can inhale and exhale. It evaluates values like the forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and the FEV1/FVC ratio. Obstructive patterns show reduced FEV1 and FVC with a low FEV1/FVC ratio while restrictive patterns have reduced FVC but a normal or increased FEV1/FVC ratio. PFTs are useful for diagnosing conditions like asthma, COPD, and inter
This is an amazing article giving brief clinical application of PFT.
Bedside PFT are best explained here.
Bedside PFT references most of times are incomplete and inadequate
COURTSEY -DEPARTMENT OF ANESTHESIA, MAMC and LOK NAYAK HOSPITAL, NEW DELHI
Spirometry is a common pulmonary function test that measures airflow in and out of the lungs. It involves taking a deep breath and then forcibly exhaling for 6 seconds into a mouthpiece connected to a spirometer. Spirometry generates key metrics like FEV1, FVC, and their ratio that are used to diagnose and monitor respiratory conditions. Interpretation involves comparing the measured values to normal predicted ranges and evaluating changes post-bronchodilator to distinguish between obstructive and restrictive lung diseases.
Pulmonary Function Tests-Nursing Maseno.pptxakoeljames8543
This document discusses various pulmonary function tests (PFTs) including spirometry. PFTs measure how well the lungs work by assessing lung volumes, airway function, and gas exchange. Spirometry specifically measures airflow and lung capacity. It involves taking a deep breath and then forcibly exhaling for 6 seconds into a spirometer. Key measurements include FEV1, FVC, and their ratio (FEV1%), which can help identify obstructive or restrictive lung diseases. Abnormal PFT results are below 80% of predicted values and indicate the severity of lung impairment. PFTs are useful diagnostic tools that also monitor treatment effectiveness.
This document provides an overview of pulmonary function tests (PFTs). It discusses various PFT measurements including spirometry, lung volumes, diffusing capacity, and airway resistance. Static and dynamic spirometry are used to measure volumes like FVC, FEV1, and ratios like FEV1/FVC. Lung volumes are typically measured using body plethysmography and provide values such as TLC, FRC, and RV. PFTs are used to diagnose obstructive and restrictive lung diseases and evaluate therapeutic interventions.
This document provides information about pulmonary function tests, specifically spirometry. It describes how spirometry is performed and what measurements are taken, including forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and ratios like FEV1/FVC. Normal values vary based on factors like age, height, sex, and race. Obstructive and restrictive lung patterns are identified based on these measurements. Spirometry is used to diagnose and monitor lung diseases.
PFTs measure lung function through tests of ventilation, gas exchange, ventilation control, and exercise response. Key measurements include FEV1, FVC, FEV1/FVC ratio, DLCO, and arterial blood gases. PFT results are interpreted to identify obstructive, restrictive, or combined patterns and determine the severity of lung abnormalities.
Pulmonary function tests (PFTs) measure how well the lungs work by assessing lung volumes, air flow, and gas exchange. PFTs can help diagnose various respiratory diseases by detecting abnormalities. The tests involve spirometry to measure volumes of air inhaled and exhaled during normal and forced breathing maneuvers. Obstructive diseases reduce air flow, shown by a decreased FEV1 and FEV1/FVC ratio. Restrictive diseases limit lung expansion, shown by a reduced FVC but normal or increased FEV1/FVC ratio. PFTs are useful for evaluating respiratory system function and the effects of treatment.
The choroid is the vascular layer of the eye located between the retina and sclera. It develops from mesenchyme surrounding the eye. The choroid consists of three layers - an outer layer of large vessels, a middle layer of medium vessels, and an inner layer of densely packed capillaries. It receives its blood supply from the short and long posterior ciliary arteries and is innervated by both the sympathetic and parasympathetic nervous systems to regulate blood flow. The choroid plays an important role in nourishing the outer retina and maintaining a smooth interface for retinal attachment.
Spirometry is a simple, inexpensive pulmonary function test used to evaluate respiratory diseases. It measures how much air a person can inhale and exhale. Sir John Hutchinson invented the first spirometer to measure vital capacity. Spirometry can identify obstructive and restrictive lung diseases, establish reversibility in asthma, screen smokers for risk, and monitor treatment effectiveness. It involves maximal inhalation and exhalation into a mouthpiece to measure volumes like forced vital capacity and flows like forced expiratory volume in one second. Graphs of the results can indicate normal lung function or patterns suggestive of various respiratory conditions.
Pulmonary function testing is the process of having the patient perform specific inspiratory and expiratory maneuvers while breathing in and out of tubing attached to the equipment that measure a variety of variables
Pulmonary function tests (PFTs) evaluate lung function through non-invasive tests. PFTs can be done at bedside or in traditional labs and include tests of lung volumes, capacities, flows and gas exchange. Bedside PFTs include breath-holding tests to assess vital capacity, single-breath tests for functional residual capacity, cough tests for strength, blowing tests for maximum breathing capacity, and peak flow tests. PFTs help diagnose and monitor pulmonary diseases, assess disease severity and surgical risk, and track response to treatment. Common diseases detected include obstructive disorders like asthma which limit expiration and restrictive disorders like fibrosis which limit both expiration and inspiration.
This document discusses pulmonary function tests (PFTs), including their goals, uses, limitations, procedures, and interpretations. PFTs are used to assess lung function before surgeries and characterize any pulmonary dysfunction. Key information obtained from PFTs includes measurements of forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), their ratio (FEV1/FVC), and peak expiratory flow rate. Interpretations of these values can indicate restrictive or obstructive lung disease. The document outlines how PFTs are performed using portable devices or clinic spirometers and flow-volume loops.
Spirometry is a common pulmonary function test that measures lung volume and airflow. It is performed using a spirometer to detect respiratory diseases like asthma and distinguish between obstructive and restrictive lung diseases. The test involves taking deep breaths and forcibly exhaling for 6 seconds to measure volumes like forced vital capacity and forced expiratory volume in 1 second. Spirometry is generally safe but may cause shortness of breath and is not performed following a heart attack or other heart conditions.
Spirometry is a test used to assess lung function by measuring airflow. It can help diagnose obstructive lung diseases like COPD and asthma by measuring airflow limitation through values like FEV1 and FEV1/FVC ratio. A spirometry report provides values for volumes of air inhaled and exhaled that are compared to predicted normal values to identify restrictive or obstructive lung abnormalities. Quality control measures ensure accurate spirometry administration and interpretation.
This document provides an overview of pulmonary function tests (PFTs). It discusses:
1. The classification and types of PFTs including mechanical ventilatory functions tests, lung volumes/capacities tests, spirometry, and gas exchange function tests.
2. How to interpret PFT results including evaluating the FEV1/FVC ratio to determine obstruction and evaluating the FVC to identify restriction.
3. Key aspects of spirometry like acceptability criteria, interpreting volume-time and flow-volume curves, and confirming restrictive patterns.
This document discusses lung volumes and capacities as measured by pulmonary function tests (PFTs). It describes the key volumes and capacities including tidal volume, inspiratory reserve volume, expiratory reserve volume, residual volume, vital capacity, total lung capacity, and functional residual capacity. It provides the normal ranges for these measurements and explains their clinical significance in assessing lung function and the presence of obstructive or restrictive lung diseases. Spirometry is highlighted as the cornerstone PFT for measuring volumes like forced vital capacity (FVC) and flows like forced expiratory volume in 1 second (FEV1).
Lung volumes and capacities can be divided into static and dynamic measurements. Static measurements do not consider time and include tidal volume, inspiratory reserve volume, expiratory reserve volume, and residual volume. Dynamic measurements involve time and include forced vital capacity, peak expiratory flow rate, and maximum voluntary ventilation. Forced vital capacity is measured in two stages after full inhalation and exhalation and provides information about respiratory muscle strength and pulmonary function. Factors like age, posture, and respiratory obstruction can impact lung volumes and capacities.
Dr. M.MADHU CHAITANYA presented on pulmonary function tests. PFTs are a battery of standardized tests used to evaluate aspects of the respiratory system, including lung mechanics, gas exchange, and cardiopulmonary interaction. Common PFTs include spirometry to measure volumes like FVC and rates like FEV1, lung volume measurements via body plethysmography or other methods, and gas exchange tests. PFTs are used to diagnose and monitor respiratory conditions, and to evaluate patients preoperatively by assessing cardiopulmonary reserve and risk of complications. The presentation covered techniques, normal values, and clinical applications of various PFTs.
Pulmonary function tests (PFTs) evaluate the different components of the respiratory system including the airways, lungs, blood vessels and chest wall muscles. Spirometry is the most common PFT and measures how much air the patient can inhale and exhale. It evaluates values like the forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and the FEV1/FVC ratio. Obstructive patterns show reduced FEV1 and FVC with a low FEV1/FVC ratio while restrictive patterns have reduced FVC but a normal or increased FEV1/FVC ratio. PFTs are useful for diagnosing conditions like asthma, COPD, and inter
This is an amazing article giving brief clinical application of PFT.
Bedside PFT are best explained here.
Bedside PFT references most of times are incomplete and inadequate
COURTSEY -DEPARTMENT OF ANESTHESIA, MAMC and LOK NAYAK HOSPITAL, NEW DELHI
Spirometry is a common pulmonary function test that measures airflow in and out of the lungs. It involves taking a deep breath and then forcibly exhaling for 6 seconds into a mouthpiece connected to a spirometer. Spirometry generates key metrics like FEV1, FVC, and their ratio that are used to diagnose and monitor respiratory conditions. Interpretation involves comparing the measured values to normal predicted ranges and evaluating changes post-bronchodilator to distinguish between obstructive and restrictive lung diseases.
Pulmonary Function Tests-Nursing Maseno.pptxakoeljames8543
This document discusses various pulmonary function tests (PFTs) including spirometry. PFTs measure how well the lungs work by assessing lung volumes, airway function, and gas exchange. Spirometry specifically measures airflow and lung capacity. It involves taking a deep breath and then forcibly exhaling for 6 seconds into a spirometer. Key measurements include FEV1, FVC, and their ratio (FEV1%), which can help identify obstructive or restrictive lung diseases. Abnormal PFT results are below 80% of predicted values and indicate the severity of lung impairment. PFTs are useful diagnostic tools that also monitor treatment effectiveness.
This document provides an overview of pulmonary function tests (PFTs). It discusses various PFT measurements including spirometry, lung volumes, diffusing capacity, and airway resistance. Static and dynamic spirometry are used to measure volumes like FVC, FEV1, and ratios like FEV1/FVC. Lung volumes are typically measured using body plethysmography and provide values such as TLC, FRC, and RV. PFTs are used to diagnose obstructive and restrictive lung diseases and evaluate therapeutic interventions.
This document provides information about pulmonary function tests, specifically spirometry. It describes how spirometry is performed and what measurements are taken, including forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and ratios like FEV1/FVC. Normal values vary based on factors like age, height, sex, and race. Obstructive and restrictive lung patterns are identified based on these measurements. Spirometry is used to diagnose and monitor lung diseases.
PFTs measure lung function through tests of ventilation, gas exchange, ventilation control, and exercise response. Key measurements include FEV1, FVC, FEV1/FVC ratio, DLCO, and arterial blood gases. PFT results are interpreted to identify obstructive, restrictive, or combined patterns and determine the severity of lung abnormalities.
Pulmonary function tests (PFTs) measure how well the lungs work by assessing lung volumes, air flow, and gas exchange. PFTs can help diagnose various respiratory diseases by detecting abnormalities. The tests involve spirometry to measure volumes of air inhaled and exhaled during normal and forced breathing maneuvers. Obstructive diseases reduce air flow, shown by a decreased FEV1 and FEV1/FVC ratio. Restrictive diseases limit lung expansion, shown by a reduced FVC but normal or increased FEV1/FVC ratio. PFTs are useful for evaluating respiratory system function and the effects of treatment.
The choroid is the vascular layer of the eye located between the retina and sclera. It develops from mesenchyme surrounding the eye. The choroid consists of three layers - an outer layer of large vessels, a middle layer of medium vessels, and an inner layer of densely packed capillaries. It receives its blood supply from the short and long posterior ciliary arteries and is innervated by both the sympathetic and parasympathetic nervous systems to regulate blood flow. The choroid plays an important role in nourishing the outer retina and maintaining a smooth interface for retinal attachment.
thesis statement is a sentence that sums up the central point of your paper or essay. It usually comes near the end of your introduction.
Your thesis will look a bit different depending on the type of essay you’re writing. But the thesis statement should always clearly state the main idea you want to get across. Everything else in your essay should relate back to this idea.
Example: Thesis statement
Despite Oscar Wilde’s Aestheticist claims that art needs no justification or purpose, his work advocates Irish nationalism, women’s suffrage, and socialism.
You can write your thesis statement by following four simple step
The retina (from "net") is the innermost, light-sensitive layer of tissue of the eye of most vertebrates and some molluscs. The optics of the eye create a focused two-dimensional image of the visual world on the retina, which then processes that image within the retina and sends nerve impulses along the optic nerve to the visual cortex to create visual perception
The retina is the tissue layer located in the back of your eye. This layer transforms light into nerve signals that are then sent to the brain for interpretation.
When your blood pressure is too high, the retina’s blood vessel walls may thicken. This may cause your blood vessels to become narrow, which then restricts blood from reaching the retina. In some cases, the retina becomes swollen.
Over time, high blood pressure can cause damage to th
orneal ulcer, also called keratitis, is an inflammatory or, more seriously, infective condition of the cornea involving disruption of its epithelial layer with involvement of the corneal stroma. It is a common condition in humans particularly in the tropics and in farming. In developing countries, children afflicted by vitamin A deficiency are at high risk for corneal ulcer and may become blind i
Dry eye disease is a common condition that occurs when your tears aren't able to provide adequate lubrication for your eyes. Tears can be inadequate and unstable for many reasons. For example, dry eyes may occur if you don't produce enough tears or if you produce poor-quality tears. This tear instability leads to inflammation and damage of the eye's surface.
Dry eyes feel uncomfortable. If you have dry eyes, your eyes may sting or burn. You may experience dry eyes in certain situations, such as on an airplane, in an air-conditioned room, while riding a bike or after looking at a computer screen for a few hours
bilateral potentially blinding condition in which obstruction to aqueous outflow is brought about solely by closure of angle by peripheral iris One eye is usually affected before the other
SUPERIOR OBLIQUE PALSY MANAGEMENT [Autosaved].pptxudayasree30
These tissues are known as trochlea. The superior oblique muscle allows the eye to be turned downward and inward. When the fourth cranial nerve is injured or diseased, it can cause paralysis of the superior oblique muscle. This is known as superior oblique palsy, trochlear nerve palsy, or fourth nerve palsy.
The International Classification of Diseases 11 (2018) classifies vision impairment into two groups, distance and near presenting vision impairment.
Distance vision impairment:
Mild – visual acuity worse than 6/12 to 6/18
Moderate – visual acuity worse than 6/18 to 6/60
Severe – visual acuity worse than 6/60 to 3/60
Blindness – visual acuity worse than 3/60
Nearsightedness (myopia) is a common vision condition in which near objects appear clear, but objects farther away look blurry. It occurs when the shape of the eye — or the shape of certain parts of the eye — causes light rays to bend (refract) inaccurately. Light rays that should be focused on nerve tissues at the back of the eye (retina) are focused in front of the retina.
Nearsightedness usually develops during childhood and adolescence, and it usually becomes more stable between the ages of 20 and 40. Myopia tends to run in families.
A basic eye exam can confirm nearsightedness. You can compensate for the blurry vision with eyeglasses, contact lenses or refractive surgery.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...Donc Test
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Study Guide Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Course Hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Answers Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Course hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Study Guide Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Ebook Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Questions Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Stuvia
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
2. • Lung volumes and lung capacities refer to volume of
air associated with different phases of the respiratory
cycle.
• Lung volumes are directly measured.
• Lung capacities are inferred from lung volumes.
• John Hutchinson invented spirometer.
• Cant Measure –FRC,RV,TLC
18/7/2021 Dr.K.Ha
ritha
2
4. • TIDAL VOLUME
• Normal volume of air inspired or expired during quiet
breathing
• Normal volume:500ml
• RESIDUAL VOLUME:
• Volume remaining in the lung after a maximal expiratory
effort
• Normal value:1200ml
18/7/2021 Dr.K.Ha
ritha
4
5. • INSPIRATORY RESERVE VOLUME:
• Volume of air that can be inspired with maximal effort
above the normal resting end expiratory position of a tidal
volume.
• Normal value:3000ml in adult male
• EXPIRATORY RESERVE VOLUME:
• Volume of air that can be forcibly exhaled between resting
end expiratory volume and RV.
• Normal value:1100ml
6. CAPACITIES
• VITAL CAPACITY:
• amount of air that can be exhaled from the point of
maximal inspiration to the point of maximal
expiration (IRV+TV+ERV).
• FORCED VITAL CAPACITY:
• Volume of air that can be exhaled with maximal
effort from total lung capacity
5
7. • TOTAL LUNG CAPACITY(TLC):
• Total volume of air in the lungs after a maximal
inspiration
• IRV+TV+ERV+RV
• FRC-FUNCTIONAL RESIDUAL CAPACITY
• Amount of air in the lung at the end of quiet
exhalation.
• ERV+RV
11. • Closing Capacity:
CC is the sum of closing volume (CV) and
RV.
Measurement is by wash in technique with a
small bolus of insoluble tracer gas xenon or by
nitrogen washout after inspiration of a breath of
oxygen from RV.
Normal value-15% to 20% of VC
Increases with age due to loss of structural
parenchymal support tissue in the lung and
increase in RV.
12. Closing volume:
CV is the lung volume below which small airways
begin to close (or at least cease to contribute
expiratory gas) during expiration.
Closure of small airways in the basal portions of the
lung during deep expiration is a normal phenomenon
due to the gravity-dependent increase in pleural
pressure at the bases and due to lack of
parenchymal support in distal airways.
13. SPIROMETRYPREREQUISITES
Do not smoke for at
least1hourbefore the
test.
Do not drink alcohol for at
least 4 hours before the test.
Do not exercise heavily for at
least 30 minutes before the
test.
Do not wear tight clothing
that makes it difficult for you
to take a deep breath.
Do not eat a large meal
within 2 hours before the test.
14. ACCEPTABILITY CRITERIA
Good start of test- without any hesitation
No Artifact (coughing / glottis closure)
No variable flow
No early termination(> 6 sec)
No air leak
REPEATABILITY CRITERIA
Two largest FVC within 150 ml of each
other
Upto 8 manoeuver can be repeated
till criteria are met
16. 1) N2 WashoutTechnique:
patient breathes 100%
oxygen
all the nitrogen in the lungs is washed
out
exhaled volume and the
nitrogen concentration are
measured.
nitrogen volume at
the initial concentration
final exhaled FRC
concentration
17. 2)HeliumDilutiontechnique:
Pt breathes in and out from a reservoir
with known volume of gas containing
trace of helium.
Helium gets diluted by gas previously
present in lungs.
18. 3)BodyPlethysmography
Plethysmography (derived from greek
word meaning enlargement). Based on
principle of BOYLE’S LAW(PV=k)
A patient is placed in a sitting position
in a closed body box with a known
volume
The patient pants with an open glottis
against a closed shutter to produce
changes in the box pressure
proportionate to the volume of air in the
chest.
As measurements done at
end of expiration, it yields FRC
20. Forced expiratory volume in 1 sec (FEV1): Volume of air
that can be forcefully exhaled in 1 sec. Values between 80%
and 120% of the predicted value are considered normal.
Forced vital capacity (FVC): The volume of air that can be
exhaled with maximum effort after a deep inhalation. Normal
values are 3.7 L in females and 4.8 L in males. Ratio of
FEV1 to FVC: This ratio in healthy adults is 75%–80%.
Forced expiratory flow at 25%–75% of vital capacity
(FEF25%– 75%): A measurement of airflow through the
midpoint of a forced exhalation.
21. Maximum voluntary ventilation (MVV): The maximum
amount of air that can be inhaled and exhaled within 1
min.
• The volume is measured over a 15-sec time period
and results are extrapolated to obtain a value for 1
min expressed as liters per minute.
• Average values for males and females are 140–180
and 80–120 L/min, respectively
22. . Diffusing capacity (Dlco):
• The volume of a substance [CO] transferred
across the alveoli into blood per minute per unit
of alveolar partial pressure.
• CO is rapidly taken up by hemoglobin and Its
transfer is therefore limited mainly by diffusion.
• A single breath of 0.3% CO and 10% helium is
held for 20 sec. Expired partial pressure of CO
is measured.
• Normal value is 17–25 mL/min/mm Hg.
26. FEV1 FVC FEV1/FVC
OBSTRUCTIVE DECREASED
(<80%)
DECREASED DECREASED(< 0.7)
RESTRICTIVE DECREASED DECREASED NORMAL OR INCREASED
27. 1) FORCED VITAL CAPACITY
Maximum volume of air that can be breathed out
as forcefully and rapidly as possible following a
maximum inspiration.
The expiration should be at least 4 seconds and
should not be interrupted by coughing, glottis
closure or mechanical obstruction.
Normal healthy subjects have VC = FVC.
Indirectly reflects flow resistance property of
airways.
Interpretation of % predicted:
>80-120% Normal
70-79% Mild reduction
50%-69% Moderate reduction
<50% Severe reduction
28. 2) FORCED EXPIRATORY VOLUME in 1 SEC.
(FEV1)
Forced expired volume in 1 sec during
FVC maneuver.
Expressed as an absolute value or % of
FVC
Normal - FEV1 (1 SEC)- 75-85% OF FVC
FEV2 (2 SEC)- 94% OF FVC
FEV3 (3 SEC)- 97% OF FVC
FEV1 – Decreased in both obstructive &
restrictive lung disorders
29.
30. FEV1%=FEV1/VC X100.
• FEV1/FVC – Reduced in obstructive
disorders.
Interpretation of FEV1 % predicted:
>80% Normal
50%-80% Mild obstruction
30%-50% Moderate
<30% Severe
A FEV1% that is too high is suggestive for a
restriction of the pulmonary volume.
31. PULMONARY
FUNCTION TESTS
Indicate group of studies or maneuvers
performed using standardized equipment
to measure lung function
Evaluate one or more aspects of the
respiratory system
Respiratory mechanics
Lung parenchymal function/ Gas
exchange
Cardiopulmonary interaction
15
32. INDICATIONS
Investigation of patients with symptoms/signs/
investigations that suggest pulmonary disease
e.g.(Cough/Wheeze/Breathlessness/Crackles)
Monitoring patients with known pulmonary
disease for progression and response to
treatment e.g.
• Interstitial fibrosis
• COPD & Asthma
• Pulmonary vascular disease
33. Investigationof patients with disease that may
have a respiratory complications e.g.
• Connective tissue disorders
• Neuromuscular diseases
Preoperative evaluation prior to
• Lung resection
• Abdominal surgery
• Cardiothoracic surgery
34. • Evaluation of patients at risk of lungdiseases
• Exposure to pulmonary toxins such as
radiation,medication,environmental,occupational,
exposure
• Surveillance following lung transplantation to
assess for
• 1)Acute rejection
• 2)Infection
• 3)Obliterative bronchiolitis
35. CONTRAINDICATIONS
• Myocardial infarction with in last month
• Unstable angina
• Recent thoracoabdominal surgery
• Recent ophthalmic surgery
• Thoracic or abdominal aneurysm
• H/o syncope with forced exhalation
• Current pneumothorax/hemoptysis
36. INDICATIONS OF PFT IN PAC
TISI GUIDELINES FOR PREOPERATIVE
SPIROMETRY
Age > 70 yrs.
Morbid obesity
Thoracic surgery
Upper abdominal surgery
Smoking history and cough
Any pulmonary disease
37. American College Of Physicians
(ACP) Guidelines For
Preoperative Spirometry
Lung resection
H/o smoking, dyspnoea
Cardiac surgery
Upper abdominal surgery
Lower abdominal surgery
Uncharacterized pulmonary
disease (defined as history of
pulmonary Disease or symptoms
and no PFT in last 60 days)
39. 1) SABRASEZ BREATHHOLDING
TEST:
Ask the patient to take a full but not too deep breath &
hold it as long as possible.
Assessment of cardio pulmonary reserve
>25 SEC - NORMAL Cardiopulmonary Reserve
(CPR)
15-25 SEC - LIMITED CPR
<15 SEC - VERY POOR CPR (Contraindication for
elective surgery)
40. 2) SCHNEIDER’S MATCH BLOWING
TEST:Ability of patient to cough &bring out secretions in post
operative period or reduction in post op atelectasis
Measures Maximum Breathing Capacity
Ask to blow a match stick from a distance of 6” (15
cms) with-
Mouth wide open
Chin rested/supported
No purse lipping
No head movement
No air movement in the room
Mouth and match at the samelevel
42. Can’t blow
out
Able to
blow
MBC < 60 L/min
FEV1 < 1.6L
Modified match test:
DISTANCE
9”
6”
3”
MBC > 60L/min
FEV1>1.6L
MBC
>150 L/MIN.
>60 L/MIN.
>40 L/MIN
43. 3.COUGH TEST
Deep breath inadequate cough if:
Followed by cough FVC<20 ml/kg
• Ability to cough FEV1<15 ml/kg
• Strength PEFR<200L/min
• Effectiveness VC-3 Times TV for
effective cough
44. 4) FORCED EXPIRATORYTIME:
After deep breath, exhale maximally and
forcefully & keep stethoscope over
trachea& listen.
Normal FET – 3-5 SECS.
OBS.LUNG DIS. - > 6 SEC
RES. LUNG DIS.- < 3 SEC
28
47. 7) DE-BONO WHISTLE BLOWING
TEST:
Measures PEFR.
Patient blows down a wide
bore tube
whistle blows
leak hole is gradually increased till the
till the intensityof whistle disappears.
The last position at which the whistle can be blown
the PEFR can be read off the scale.
,
48. 8) WRIGHT RESPIROMETER:
measures TV, MV
Instrument- compact, light and portable.
Can be connected to endotracheal tube or face
mask
MV- instrument record for 1
min. and read directly
TV-calculated by dividing
MV by counting Respiratory
Rate.
Disadvantage: It under-
reads at low flow rates and
over- reads
at high flow rates.
49. 9)SPHYGMOMANOMETER BLOW
TEST (endurancetest):
-Ask to blow and raise column of Hg
upto 40- 50 mmHg and duration is
noted.
-50 seconds is normal.
10)MICROSPIROMETERS;Measure
VC
11) BED SIDE PULSE OXIMETRY
12) ABG.